ResearcherUniversity of OxfordNo recent work listed
James Matthew Wilson
Matched on ORCID iD 0000-0003-2444-9171; OpenAlex author ID A5037132641. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper
Papers 3
- Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after … Co-author DOI 10.1016/j.clon.2017.01.038↗
- ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer. Co-author DOI 10.1016/j.radonc.2016.03.021↗
- Challenges in using ¹⁸F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer. Co-author DOI 10.1186/1748-717x-9-146↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- M. Hawkins · 3 shared papers, 2014–2017 · strength 0.19
- Paper Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in L… DOI 10.1016/j.clon.2017.01.038↗
- Paper Challenges in using ¹⁸F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced … DOI 10.1186/1748-717x-9-146↗
- Paper ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advance… DOI 10.1016/j.radonc.2016.03.021↗
- Thomas Baptist Brunner · 3 shared papers, 2014–2017 · strength 0.19
- Paper Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in L… DOI 10.1016/j.clon.2017.01.038↗
- Paper Challenges in using ¹⁸F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced … DOI 10.1186/1748-717x-9-146↗
- Paper ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advance… DOI 10.1016/j.radonc.2016.03.021↗
- Somnath Mukherjee · 3 shared papers, 2014–2017 · strength 0.19
- Paper Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in L… DOI 10.1016/j.clon.2017.01.038↗
- Paper Challenges in using ¹⁸F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced … DOI 10.1186/1748-717x-9-146↗
- Paper ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advance… DOI 10.1016/j.radonc.2016.03.021↗
- Mike Partridge · 3 shared papers, 2014–2017 · strength 0.19
- Paper Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in L… DOI 10.1016/j.clon.2017.01.038↗
- Paper Challenges in using ¹⁸F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced … DOI 10.1186/1748-717x-9-146↗
- Paper ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advance… DOI 10.1016/j.radonc.2016.03.021↗
- Tim Maughan · 1 shared paper, 2016 · strength 0.05
- Emmanouil Fokas Fokas · 1 shared paper, 2016 · strength 0.05
- Eric E. O’Neill · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.